BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 8863812)

  • 1. Design and synthesis of histidine analogues of folic acid and methotrexate as potential folylpolyglutamate synthetase inhibitors.
    Mao Z; Pan J; Kalman TI
    J Med Chem; 1996 Oct; 39(21):4340-4. PubMed ID: 8863812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
    Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate analogues. 26. Inhibition of dihydrofolate reductase and folylpolyglutamate synthetase activity and in vitro tumor cell growth by methotrexate and aminopterin analogues containing a basic amino acid side chain.
    Rosowsky A; Freisheim JH; Moran RG; Solan VC; Bader H; Wright JE; Radike-Smith M
    J Med Chem; 1986 May; 29(5):655-60. PubMed ID: 2871191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biologic activity of new side-chain-altered methotrexate and aminopterin analogs with dual inhibitory action against dihydrofolate reductase and folylpolyglutamate synthetase.
    Rosowsky A; Moran RG; Freisheim JH; Bader H; Forsch RA; Solan VC
    NCI Monogr; 1987; (5):145-52. PubMed ID: 3431589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-deazafolate analogues with a rotationally restricted glutamate or ornithine side chain: synthesis and binding interaction with folylpolyglutamate synthetase.
    Rosowsky A; Forsch RA; Null A; Moran RG
    J Med Chem; 1999 Sep; 42(18):3510-9. PubMed ID: 10479284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinazoline thymidylate synthase inhibitors: methods for assessing the contribution of polyglutamation to their in vitro activity.
    Jackman AL; Kimbell R; Brown M; Brunton L; Boyle FT
    Anticancer Drug Des; 1995 Oct; 10(7):555-72. PubMed ID: 7495479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogs.
    Sanghani PC; Jackman A; Evans VR; Thornton T; Hughes L; Calvert AH; Moran RG
    Mol Pharmacol; 1994 Feb; 45(2):341-51. PubMed ID: 8114682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate analogues. 34. Replacement of the glutamate moiety in methotrexate and aminopterin by long-chain 2-aminoalkanedioic acids.
    Rosowsky A; Bader H; Kohler W; Freisheim JH; Moran RG
    J Med Chem; 1988 Jul; 31(7):1338-44. PubMed ID: 2898531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-based inhibitors of folylpoly-gamma-glutamate synthetase and gamma-glutamyl hydrolase: control of folylpoly-gamma-glutamate homeostasis as a drug target.
    Coward JK; McGuire JJ
    Vitam Horm; 2008; 79():347-73. PubMed ID: 18804701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human liver folylpolyglutamate synthetase by non-gamma-glutamylatable antifolate analogs.
    Clarke L; Rosowsky A; Waxman DJ
    Mol Pharmacol; 1987 Jan; 31(1):122-7. PubMed ID: 3807889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and growth inhibition studies of methotrexate and aminopterin analogues containing a tetrazole ring in place of the gamma-carboxyl group.
    McGuire JJ; Russell CA; Bolanowska WE; Freitag CM; Jones CS; Kalman TI
    Cancer Res; 1990 Mar; 50(6):1726-31. PubMed ID: 2306727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate analogues. 32. Chain extension, alpha-carboxyl deletion, and gamma-carboxyl replacement by sulfonate and phosphonate: effect on enzyme binding and cell-growth inhibition.
    Rosowsky A; Forsch RA; Moran RG; Kohler W; Freisheim JH
    J Med Chem; 1988 Jul; 31(7):1326-31. PubMed ID: 3385729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-based inhibition of human folylpolyglutamate synthetase: design, synthesis, and biochemical characterization of a phosphapeptide mimic of the tetrahedral intermediate.
    Tsukamoto T; Haile WH; McGuire JJ; Coward JK
    Arch Biochem Biophys; 1998 Jul; 355(1):109-18. PubMed ID: 9647673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differing specificities for 4-aminofolate analogues of folylpolyglutamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action.
    Rumberger BG; Barrueco JR; Sirotnak FM
    Cancer Res; 1990 Aug; 50(15):4639-43. PubMed ID: 2369741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of folic acid and methotrexate analogues containing L-threo-(2S,4S)-4-fluoroglutamic acid and DL-3,3-difluoroglutamic acid.
    Hart BP; Haile WH; Licato NJ; Bolanowska WE; McGuire JJ; Coward JK
    J Med Chem; 1996 Jan; 39(1):56-65. PubMed ID: 8568827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 6,5-fused ring heterocyclic antifolates: biochemical and biological characterization.
    McGuire JJ; Bergoltz VV; Heitzman KJ; Haile WH; Russell CA; Bolanowska WE; Kotake Y; Haneda T; Nomura H
    Cancer Res; 1994 May; 54(10):2673-9. PubMed ID: 8168096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate analog nonsubstrates and inhibitors of folylpolyglutamate synthetase as potential cancer chemotherapy drugs.
    McGuire JJ; Piper JR; Coward JK; Galivan J
    NCI Monogr; 1987; (5):139-44. PubMed ID: 2448652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DL-beta,beta-difluoroglutamic acid mediates position-dependent enhancement or termination of pteroylpoly(gamma-glutamate) synthesis catalyzed by folylpolyglutamate synthetase.
    McGuire JJ; Hart BP; Haile WH; Rhee MS; Galivan J; Coward JK
    Arch Biochem Biophys; 1995 Aug; 321(2):319-28. PubMed ID: 7646057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate analogues. 33. N delta-acyl-N alpha-(4-amino-4-deoxypteroyl)-L-ornithine derivatives: synthesis and in vitro antitumor activity.
    Rosowsky A; Bader H; Cucchi CA; Moran RG; Kohler W; Freisheim JH
    J Med Chem; 1988 Jul; 31(7):1332-7. PubMed ID: 3385730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
    Zhao R; Babani S; Gao F; Liu L; Goldman ID
    Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.